Table 4 Proportion of participants with at least one prescription for the listed classes of medicine
From: Increased respiratory morbidity in individuals with interstitial lung abnormalities
Medication | ILA | No ILA | P-value |
|---|---|---|---|
Inhalation therapy | 72 (22%) | 316 (19%) | 0.009 |
Antibiotic therapy | 277 (83%) | 1337 (81%) | 0.002 |
Prednisolone | 27 (8%) | 130 (8%) | 0.63 |
Proton pump inhibitors | 111 (33%) | 482 (29%) | 0.07 |
Antithrombotic therapy | 98 (30%) | 361 (22%) | 0.35 |
Antihypertensive therapy | 77 (23%) | 348 (21%) | 0.09 |
Loop diuretics | 27 (8%) | 79 (5%) | 0.008 |
Lipid lowering therapy | 108 (33%) | 517 (31%) | 0.64 |
Antidiabetic therapy | 75 (23%) | 335 (20%) | 0.86 |